What PopVax does
Founded in 2021, PopVax operates in Health Tech offering novel mRNA vaccines and therapeutics developed through computational protein design. The company is currently focused on a next-generation COVID-19 booster vaccine expected to enter Phase I clinical trials in the U.S., aimed at providing broader protection against emerging SARS-CoV-2 variants. With a team of over 70 specialists in various fields, PopVax undertakes its research and production at its facility in Hyderabad. The company's mission is to save one million lives annually over the next decade by developing and distributing vaccines for infectious diseases.
Who runs it
Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.
Questions and experiences
Nobody has asked anything about PopVax yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.
Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.